Langerhans cell histiocytosis misdiagnosed as liver cancer and pituitary tumor in an adult: A case report and brief review of the literature
- Authors:
- Jing Ma
- Yongfang Jiang
- Xiangyu Chen
- Guozhong Gong
View Affiliations
Affiliations: Department of Hepatitis Diseases, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China
- Published online on: February 28, 2014 https://doi.org/10.3892/ol.2014.1928
-
Pages:
1602-1604
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Langerhans cell histiocytosis (LCH) is a rare proliferative disorder in which pathological Langerhans cells accumulate in a variety of organs. LCH usually affects the bone, skin and lymph nodes of children; however, LCH occasionally affects vital organs, including the liver, spleen and pituitary gland. The present study reports a case of an adult LCH patient with marked liver damage, splenomegaly and pituitary damage treated using a new therapeutic strategy. This case was misdiagnosed as liver cancer and pituitary tumor on the basis of abdominal ultrasound, abdominal magnetic resonance imaging (MRI) and head MRI. The final diagnosis was established by identifying the proliferation of cluster of differentiation 1a‑positive LCs in liver tissues. A new regimen of combined 12‑week therapy of prednisolone/desmopressin/vincristine and 10 months of maintenance therapy of prednisolone/vinblastine/6‑mercaptopurine improved symptoms, liver function and blood cell tests.
View References
|
1
|
Leonidas JC, Guelfguat M and Valderrama E:
Langerhans’ cell histiocytosis. Lancet. 361:1293–1295. 2003.
|
|
2
|
Gasent Blesa JM, Alberola Candel V, Solano
Vercet C, et al: Langerhans cell histiocytosis. Clin Transl Oncol.
10:688–696. 2008.
|
|
3
|
García Gallo MS, Martínez MP, Abalovich
MS, et al: Endocrine manifestations of Langerhans cell
histiocytosis diagnosed in adults. Pituitary. 13:298–303.
2010.PubMed/NCBI
|
|
4
|
Camelo-Piragua S, Zambrano E and
Pantanowitz L: Langerhans cell histiocytosis. Ear Nose Throat J.
89:112–113. 2010.
|
|
5
|
Howarth DM, Gilchrist GS, Mullan BP,
Wiseman GA, Edmonson JH and Schomberg PJ: Langerhans cell
histiocytosis: diagnosis, natural history, management, and outcome.
Cancer. 85:2278–2290. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Minkov M, Grois N, McClain K, et al:
Langerhans Cell Histiocytosis. Histiocyte Society Evaluation and
Treatment Guidelines. 2009.
|
|
7
|
Kilpatrick SE, Wenger DE, Gilchrist GS, et
al: Langerhans’ cell histiocytosis (histiocytosis X) of bone. A
clinicopathologic analysis of 263 pediatric and adult cases.
Cancer. 76:2471–2484. 1995.
|
|
8
|
Mampaey S, Warson F, Van Hedent E and De
Schepper AM: Imaging findings in Langerhans’ cell histiocytosis of
the liver and the spleen in an adult. Eur Radiol. 9:96–98.
1999.
|
|
9
|
Redhu R, Nadkarni T and Mahesh R: Diabetes
insipidus associated with a thickened pituitary stalk in a case of
Langerhans cell histiocytosis. J Pediatr Neurosci. 6:62–64.
2011.
|
|
10
|
Lieberman PH, Jones CR, Steinman RM, et
al: Langerhans cell (eosinophilic) granulomatosis. A
clinicopathologic study encompassing 50 years. Am J Surg Pathol.
20:519–552. 1996.
|
|
11
|
Broadbent V, Gadner H, Komp DM and Ladisch
S: Histiocytosis syndromes in children: II. Approach to the
clinical and laboratory evaluation of children with Langerhans cell
histiocytosis Clinical Writing Group of the Histiocyte Society. Med
Pediatr Oncol. 17:492–495. 1989. View Article : Google Scholar
|
|
12
|
Minkov M, Grois N, Heitger A, et al:
Treatment of multisystem LCH. Results of DAL-HX 83 and DAL-HL 90
studies DAL-HX study group. Klin Padiatr. 212:139–144. 2000.
View Article : Google Scholar : PubMed/NCBI
|
